European Society of Cardiology
Welcome to the European Society of Cardiology
 
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Our mission: to reduce the burden of cardiovascular disease in Europe
 

European Heart Rhythm Association (EHRA)

To improve the quality of life of the European population by reducing the impact of cardiac arrhythmias and reduce sudden cardiac death.

The European Heart Rhythm Association (EHRA) is an association specialising in cardiac electrophysiology. Its ambition is to serve as the leading organisation in the field of arrhythmias and electrophysiology in Europe, and to attract all physicians from Europe and beyond to foster the development of this area of expertise.


 

Lars Wallentin, FESC, comments on behalf of the European Society of Cardiology on the late breaking clinical trials on arrhythmias presented at ACC.10 in Atlanta.


Interested in the European perspective of ACC.10? Connect to the ESC!
The ESC Communications Team is attending ACC.10 in Atlanta, providing live coverage of the conference.

 More videosMore videos from the European Society of Cardiology (ESC)

 

Quick Actions

Become a Member

Apply for Training Fellowships

Subscribe to our Journal

Attend the EHRA Courses

Read latest news

Congress reports

Molecular characteristics of arrhythmogenic substrates
31 August 2009
Elisabetta Cerbai

Elisabetta Cerbai

Highlights of the European Heart Rhythm Association's consensus documents 
31 August 2009
Angel Moya I Mitjans

Angel Moya i Mitjans

Arrhythmia highlights - Our web committee's choice

  • Pericardial effusion in atrial fibrillation ablation: a comparison between cryoballoon and radiofrequency pulmonary vein isolation.
    Chierchia GB et al. Europace. 2010; 1: 337-341. Read more
  • Time for action regarding cardiovascular emergency care at sports arenas: a lesson from the arena study.
    Borjesson M, et al. Eur Heart J 2010, doi: 10.1093/eurheartj/ehq006. Read more
  • Uninterrupted warfarin for periprocedural anticoagulation in catheter ablation of typical atrial flutter: A safe and cost-effective strategy.
    Finlay M et al. J Cardiovasc Electrophysiol. 2009; 21: 150-154. Read more
  • Direct transthoracic access to the left ventricle for catheter ablation of ventricular tachycardia.
    Hsieh CH, et al. Circ Arrhythm Electrophysiol doi:10.1161/CIRCEP.109.906628. Read more
  • KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders.
    Jie Wu et al. Heart Rhythm. 2010; 7: 199-205.. Read more